Karin von Wachenfeldt
Medicon Village(SE)Lund Science (Sweden)(SE)
Publications by Year
Research Areas
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Inhalation and Respiratory Drug Delivery, Immune Cell Function and Interaction
Most-Cited Works
- → Cigarette smoke extract modulates respiratory defence mechanisms through effects on T-cells and airway epithelial cells(2005)64 cited
- → Novel Prostaglandin D Synthase Inhibitors Generated by Fragment-Based Drug Design(2008)63 cited
- → A novel IgE-neutralizing antibody for the treatment of severe uncontrolled asthma(2014)52 cited
- → Targeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaques(2013)48 cited
- → C-36 peptide, a degradation product of α1-antitrypsin, modulates human monocyte activation through LPS signaling pathways(2005)42 cited
- → Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers(2007)33 cited
- → Systemic CD4+ T-cell activation is correlated with FEV1 in smokers(2005)32 cited
- → Imaging Biomarkers and Pathobiological Profiling in a Rat Model of Drug-Induced Interstitial Lung Disease Induced by Bleomycin(2020)28 cited
- → Rationale and Emerging Approaches for Targeting Lung Repair and Regeneration in the Treatment of Chronic Obstructive Pulmonary Disease(2011)24 cited
- → Longitudinal Imaging Using PET/CT with Collagen-I PET-Tracer and MRI for Assessment of Fibrotic and Inflammatory Lesions in a Rat Lung Injury Model(2020)23 cited